This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cavallari, L. H. Articles by Geenen, D. L. Search for Related Content PubMed PubMed Citation Articles by Cavallari, L. H. Articles by Geenen, D. L. Social Bookmarking                         What's this?

Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression

Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA, humma{at}uic.edu

Lucy A. Fashingbauer

Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA

Joseph R. Camp

Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA

Stephen T. King

Research Resources Center, University of Illinois at Chicago, Chicago, IL 60612, USA

David L. Geenen

Department of Medicine, Section of Cardiology and Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL 60612, USA

Introduction. Aldosterone promotes renal fibrosis via the mineralocorticoid receptor (MR), thus contributing to hypertension-induced nephropathy. We investigated whether MR gene expression influences renal fibrosis and MR antagonist response in a two-kidney, one-clip hypertensive rat model.

Materials and methods. Brown Norway (BN), Lewis, and ACI rats were randomised to spironolactone 20 mg/kg/day or water by gavage, starting four weeks after left renal artery clipping. Blood pressure was measured bi-weekly by tail cuff. After eight weeks of treatment, right kidneys were removed and examined for fibrosis and gene expression. Rats of each strain undergoing no intervention served as controls.

Results. Blood pressure increased similarly among strains after clipping and was unaffected by spironolactone. Hypertension caused the greatest renal fibrosis in BN rats (p < 0.001 by ANOVA compared to other strains). Real-time PCR analysis showed greater renal collagen type I and MR gene expression in untreated, hypertensive BN rats (both p < 0.05 compared to other strains). Spironolactone attenuated fibrosis, with similar fibrosis among strains of spironolactone-treated rats.

Conclusion. Hypertension-induced renal fibrosis was greatest in rats with the highest MR gene expression. Spironolactone abolished inter-strain differences in fibrosis. Our data suggest that MR genotype may influence aldosterone-induced renal damage, and consequently, renal response to aldosterone antagonism.

Key Words: aldosterone • collagen • fibrosis • gene • hypertension • kidney • mineralocorticoid • pharmacogenetics • spironolactone

References

• Greene EL, Kren S., Hostetter TH Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996;98: 1063-8.[Web of Science][Medline] [Order article via Infotrieve]
• Blasi ER, Rocha R., Rudolph AE, Blomme EA, Polly ML, McMahon EG Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003;63:1791-800.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Peng H., Carretero OA, Raij L., Yang F., Kapke A., Rhaleb NE Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension 2001;37:794-800.[Abstract/Free Full Text]
• Lombes M., Farman N., Oblin ME et al. Immunohistochemical localization of renal mineralocorticoid receptor by using an antiidiotypic antibody that is an internal image of aldosterone. Proc Natl Acad Sci USA 1990;87:1086-8.[Abstract/Free Full Text]
• Sato A., Hayashi K., Naruse M., Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003;41(1):64-8.[Abstract/Free Full Text]
• Sato A., Hayashi K., Saruta T. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease. Am J Hypertens 2005;18(1):44-9.[Web of Science][Medline] [Order article via Infotrieve]
• Rachmani R., Slavachevsky I., Amit M. et al. The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. Diabet Med 2004;21:471-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schelling JR, Zarif L., Sehgal A., Iyengar S., Sedor JR Genetic susceptibility to end-stage renal disease. Curr Opin Nephrol Hypertens 1999;8:465-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bidani AK, Griffin KA, Churchill PC, Churchill MC, St Lezin E., Kurtz TW Genetic susceptibility to renal injury in hypertension. Exp Nephrol 2001;9:360-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cavallari LH, Groo VL, Momary KM, Fontana D., Viana MA, Vaitkus P. Racial differences in potassium response to spironolactone in heart failure. Congest Heart Fail 2006;12: 200-05.[CrossRef][Medline] [Order article via Infotrieve]
• Turner ST, Schwartz GL, Boerwinkle E. Personalized medicine for high blood pressure. Hypertension 2007;50(1):1-5.[Free Full Text]
• Arnett DK, Claas SA, Glasser SP Pharmacogenetics of antihypertensive treatment. Vascul Pharmacol 2006;44: 107-18.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Smits BM, van Zutphen BF, Plasterk RH, Cuppen E. Genetic variation in coding regions between and within commonly used inbred rat strains. Genome Res 2004;14:1285-90.[Abstract/Free Full Text]
• Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967;18:267-73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chiariello M., Ambrosio G., Cappelli-Bigazzi M., Perrone-Filardi P., Brigante F., Sifola C. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol 1986;18:283-90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pfaffl MW A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29 (9):e45.[Abstract/Free Full Text]
• Wang X., Ajikobi DO, Salevsky FC, Cupples WA Impaired myogenic autoregulation in kidneys of Brown Norway rats. Am J Physiol Renal Physiol 2000;278:F962-F969.[Abstract/Free Full Text]
• Churchill PC, Churchill MC, Bidani AK et al. Genetic susceptibility to hypertension-induced renal damage in the rat. Evidence based on kidney-specific genome transfer. J Clin Invest 1997;100:1373-82.[Web of Science][Medline] [Order article via Infotrieve]
• Castren M., Trapp T., Berninger B., Castren E., Holsboer F. Transcriptional induction of rat mineralocorticoid receptor gene in neurones by corticosteroids. J Mol Endocrinol 1995;14:285-93.[Abstract/Free Full Text]
• Takeda M., Tatsumi T., Matsunaga S. et al. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Hypertens Res 2007;30:427-37.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nagata K., Obata K., Xu J. et al. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 2006;47: 656-64.[Abstract/Free Full Text]
• Lemarie CA, Paradis P., Schiffrin EL New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone. J Mol Med 2008;86:673-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Callera GE, Montezano AC, Yogi A. et al. c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension 2005;46:1032-8.[Abstract/Free Full Text]
• Eil C., Edelson SK The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors. J Clin Endocrinol Metab 1984;59(1):51-5.[Abstract/Free Full Text]
• Xu Q., Wells CC, Garman JH, Asico L., Escano CS, Maric C. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension 2008;51:1218-24.[Abstract/Free Full Text]
• Metcalfe PD, Leslie JA, Campbell MT, Meldrum DR, Hile KL, Meldrum KK Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrinol Metab 2008;294:E435-443.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 9, No. 3, 146-153 (2008)
DOI: 10.1177/1470320308096367


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cavallari, L. H. Articles by Geenen, D. L. Search for Related Content PubMed PubMed Citation Articles by Cavallari, L. H. Articles by Geenen, D. L. Social Bookmarking                         What's this?